TNF and inflammatory bowel disease: TNFR1 signalling is unequivocally connected with IBD pathogenesis, as best demonstrated by the wide-spread use of anti-TNF therapeutics in IBD patients [181,182], and the clinical benefits observed in pre-clinical IBD models using drugs targeting downstream TLR/TNFR1 inflammatory signalling molecules [183].